PharmaLogic Executive and Leadership Team

Etienne Montagut, the President & Chief Executive Officer at PharmaLogic, directs the overarching corporate strategy for the global contract development and manufacturing organization. Montagut architects long-term growth initiatives by aligning diagnostic and therapeutic radiopharmaceutical production with evolving market demands across North America and Europe. By coordinating with the Board and senior leadership, the President & Chief Executive Officer ensures operational excellence within the network of radiopharmacies. Etienne Montagut drives the expansion of clinical and commercial product distribution to pharmaceutical partners, maintaining high standards for quality and regulatory compliance. This leadership role involves constant evaluation of the competitive landscape to secure market position. Through rigorous oversight of manufacturing facilities, the President & Chief Executive Officer optimizes resource allocation to support the delivery of life-saving medical products. Ultimately, Montagut fosters innovation to sustain the company's status as a leader in the radiopharmaceutical sector.

Mark Dmytruk, the Chief Financial Officer at PharmaLogic, manages the fiscal health and capital allocation strategies for the global CDMO. Dmytruk oversees financial planning, reporting, and risk management to ensure the stability of manufacturing operations across North America and Europe. By analyzing market trends in radiopharmaceuticals, the Chief Financial Officer provides data-driven insights that guide investment in new diagnostic and therapeutic technologies. Mark Dmytruk collaborates with executive leadership to optimize cost structures and improve operational efficiency within the radiopharmacy network. This role involves managing investor relations and ensuring transparency in financial disclosures to support corporate growth objectives. Through precise financial modeling, the Chief Financial Officer enables the company to scale production capabilities effectively. Dmytruk secures the necessary funding to maintain the infrastructure required for distributing clinical and commercial products to healthcare providers worldwide, ensuring long-term financial viability for the organization.

Timothy Quinton, the President at PharmaLogic, directs the operational execution and manufacturing performance of the global CDMO. Quinton architects the daily workflows within the network of radiopharmacies and manufacturing facilities across North America and Europe to ensure the timely delivery of diagnostic and therapeutic products. By coordinating with site managers and supply chain teams, the President optimizes production schedules to meet the needs of pharmaceutical partners and healthcare providers. Timothy Quinton monitors operational metrics to drive efficiency and quality improvements across all manufacturing sites. This leadership role involves implementing process enhancements that support the scaling of clinical and commercial radiopharmaceutical output. Through direct oversight of operational logistics, the President ensures the company maintains its competitive edge in the market. Quinton drives the integration of new manufacturing technologies, ensuring the organization consistently meets the high-precision requirements of the radiopharmaceutical sector while maintaining strict safety protocols.

Hallie Pierson, the Chief People Officer at PharmaLogic, directs human capital strategy to support the global manufacturing and development workforce. Pierson architects talent acquisition, leadership development, and organizational culture initiatives across the company's North American and European facilities. By aligning workforce capabilities with the technical demands of radiopharmaceutical production, the Chief People Officer ensures the organization retains top-tier expertise in diagnostic and therapeutic fields. Hallie Pierson manages performance management systems and employee engagement programs to drive operational productivity. This leadership role involves fostering a collaborative environment that supports the complex requirements of a CDMO. Through strategic workforce planning, the Chief People Officer enables the company to scale operations while maintaining high safety and quality standards. Pierson implements policies that promote professional growth, ensuring the organization possesses the necessary talent to deliver critical medical products to pharmaceutical partners and healthcare providers globally.

Pamela Wong, the Chief Legal Officer at PharmaLogic, manages all legal affairs, regulatory compliance, and intellectual property protection for the global CDMO. Wong architects strategies to navigate the complex regulatory landscape governing radiopharmaceuticals across North America and Europe. By overseeing contract negotiations with pharmaceutical partners and healthcare providers, the Chief Legal Officer ensures the protection of the company's diagnostic and therapeutic innovations. Pamela Wong provides counsel on corporate governance and risk mitigation to support the executive team's strategic decisions. This role involves maintaining rigorous adherence to safety and manufacturing standards within the radiopharmacy network. Through proactive legal oversight, the Chief Legal Officer safeguards the organization against potential liabilities while facilitating international expansion. Wong drives the development of compliance frameworks that allow for the seamless distribution of clinical and commercial products, ensuring the company operates within the strict legal parameters of the pharmaceutical industry.